Allinaire Therapeutics, LLC

Shaker Heights, OH

UEI
K5GFMW6QF1P7
CAGE
7KPN9
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
20600 Chagrin Blvd #210, Shaker Heights, OH 44122, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Humanized emap II MAB as a novel therapy for viral-associated lung injury R41HL135945 National Heart Lung and Blood Institute (NIH) $281,155
The role of emap II in viral-associated acute respiratory distress syndrome W81XWH1710177 Medical Command (Army) $210,984
46TH international school and conference on the physics of semiconductors W911NF1710125 ACC Aberdeen Proving Ground $3,500
Development of a fully humanized antibody for treating lung emphysema R44HL127873 National Heart Lung and Blood Institute (NIH) $1,673,916
Development of a fully humanized antibody for treating lung emphysema R43HL127873 National Institutes of Health $279,779

Quick answers

Is Allinaire Therapeutics, LLC registered in SAM.gov?

Yes. Allinaire Therapeutics, LLC's SAM.gov registration is active through September 2, 2027.

What is Allinaire Therapeutics, LLC's most recent federal award?

Allinaire Therapeutics, LLC's most recent federal grant award is Humanized emap II MAB as a novel therapy for viral-associated lung injury (R41HL135945), from National Heart Lung and Blood Institute (NIH), on February 15, 2018.

On GovTribe

See Allinaire Therapeutics, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login